MedPath

Feasibility and effectiveness of telehealth exercise in Systemic Lupus Erythematosus

Not Applicable
Completed
Conditions
Systemic Lupus Erythematosus
Musculoskeletal - Other muscular and skeletal disorders
Inflammatory and Immune System - Autoimmune diseases
Registration Number
ACTRN12622000063718
Lead Sponsor
Stephanie Frade
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
7
Inclusion Criteria

•Adults (18+)
•Diagnosis of systemic lupus erythematosus by the classification criteria ACR and the 2019 EULAR Classification Criteria for systemic lupus erythematosus.
•Complete the Exercise & Sports Science Australia (ESSA) adult-pre-screening tool and be stratified as low-moderate risk. If they are deemed to be moderate-high risk, more information may need to be sought from their regular treating physician to determine their eligibility for inclusion.
•Access to a computer/phone/tablet and internet connection.

Exclusion Criteria

•Currently pregnant.
•Absolute contraindications including: Present and significant lupus nephritis, myocarditis, or pericarditis.
•Relative contraindications will be informed by the screening tool and correspondence from their regular treating physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adherence to the 8-week intervention. This will be measured by recording the number of sessions that participants attended/missed.[8 weeks post-intervention commencement];Telehealth usability and satisfaction of the 8-week intervention. This is a composite outcome derived from results from one questionnaire that includes questions about both the usability and satisfaction of the telehealth intervention. This will be measured using a previously validated questionnaire titled telehealth usability and satisfaction questionnaire.[8 weeks post-intervention commencement];Personal experience and satisfaction of the program. This will be measured by a self-created semi-structured one on one interview that was designed specifically for this study.[8 weeks post-intervention commencement]
Secondary Outcome Measures
NameTimeMethod
Fatigue. This will be measured by FACIT- F (functional assessment of chronic illness therapy)[Baseline & 8 weeks post-intervention commencement];Quality of life. This will be measured by SF36 (short form-36 item questionnaire)[Baseline & 8 weeks post-intervention commencement];Upper body muscular endurance. This will be measured using a 30-second arm curl test.[Baseline & 8 weeks post-intervention commencement];Lower body muscular endurance. This will be measured using a 30-second sit-to-stand test.[Baseline & 8 weeks post-intervention commencement];Lower body muscular strength. This will be measured using a five-time sit-to-stand test.[Baseline & 8 weeks post-intervention commencement];Aerobic capacity. This will be measured using a 2-minute step test.[Baseline & 8 weeks post-intervention commencement]
© Copyright 2025. All Rights Reserved by MedPath